Hsbc (HSBA.L) traded up 0.99 % during a 24 hours period ending at 09:47 PM Central Europe on Tuesday 27th. One Hsbc stock can currently be bought for about GBX 1,291.4 on popular exchanges. Current supply of Hsbc stocks is 171 mn. Hsbc has a current market capitalization of GBX 312.9 bn and approximately GBX 33.8 bn worth of Hsbc was traded on exchanges in the last 24 hours. Since last month end, Hsbc has traded -9.96 % down. Simple moving average of last 200 days is at GBX 1,376.13. The highest price of past 52 weeks was recorded at GBX 1,610 on 08/04/2026. 52 weeks low was at GBX 79.58 on 12/26/2025.

Summary of the latest news for Hsbc

HSBC Holdings plc reported mixed results for the third quarter, with earnings that exceeded some expectations but fell short of revenue forecasts. The bank noted a significant rise in pre‑tax profit, driven largely by higher interest income and lower provision costs, yet its wealth‑management revenue lagged behind projections. Share buyback plans were reaffirmed, and the bank maintained its guidance for net interest income. Analysts expressed concern that the bank’s earnings per share outlook for 2026‑2028 may settle in the lower single‑digit range, reflecting pressure on net interest margins and wealth‑business growth. In the broader market, European indices edged lower, partly on the back of HSBC’s performance and a cautious stance ahead of forthcoming central‑bank meetings and technology earnings. The bank’s market capitalisation remains the largest outside China and the United States, with a valuation of approximately €260 billion.

Here is how related stocks have performed in the past 24 hours:

  • Brightstar Lottery (BRSL) traded up 0.21 % and now trades at USD 9.46. Current market capitalisation for Brightstar Lottery is USD 1.7 bn. Brightstar Lottery has a current price to earnings ratio of 9.5. BrightStar Lottery Plc reported a mixed performance in the latest financial update. While the company achieved a modest increase in revenue, the earnings per share fell short of market expectations, leading to a decline in share price. Analysts noted that the company’s operating margin remained stable, but the lower net profit margin and reduced dividend payout raised concerns among investors. BrightStar’s management emphasized its commitment to expanding its gaming portfolio and strengthening its digital platform, hoping to drive future growth. Despite the short-term setback, the company’s strategic initiatives and market position continue to support a cautious outlook for stakeholders.

  • Astrazeneca (AZN.L) traded up 0.23 % and now trades at GBX 12,822. Astrazeneca has a market capitalisation of GBX 266.3 bn. Astrazeneca has a current price to earnings ratio of 25.64. AstraZeneca PLC announced that its antibody‑drug conjugate Enhertu has received European Union approval as an adjuvant therapy for adult patients with residual HER2‑positive early breast cancer following neoadjuvant treatment. The decision follows the European Commission’s endorsement of the positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use, based on outcomes from the Phase III DESTINY‑Breast05 trial. The approval marks the first EU sanction of Enhertu in a curative‑intent early‑breast‑cancer setting and is expected to broaden treatment options for patients who remain at high risk of recurrence after surgery. The collaboration with Daiichi Sankyo will trigger a milestone payment, while sales of Enhertu in most EU territories will be accounted for by Daiichi Sankyo. The decision is part of AstraZeneca’s broader oncology strategy, which includes further development of antibody‑drug conjugates and other innovative therapies.

  • Capri (CPRI) traded down -1.89 % and now trades at USD 15.37. Current market capitalisation for Capri is USD 1.8 bn. Capri has a current price to earnings ratio of 20.73.

  • Nomad Foods (NOMD) traded down -1.25 % and now trades at USD 11.8. Current market capitalisation for Nomad Foods is USD 1.7 bn. Current price/earnings ratio for Nomad Foods is 12.39.

  • Immunocore (IMCR) traded up 0.97 % and now trades at USD 31.95. Immunocore has a market capitalisation of USD 1.6 bn.

About Hsbc

HSBC Holdings PLC is a financial institution operating internationally, offering a wide range of banking and financial services such as retail and corporate banking, trade, trusteeship, securities, custody, capital markets, treasury, private and investment banking, and insurance. Their website is accessible under www.hsbc.com and they are listed on the London Stock Exchange.